Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.3 - $1.31 $34,558 - $150,905
-115,195 Reduced 88.07%
15,600 $5,000
Q1 2022

May 16, 2022

SELL
$0.61 - $1.84 $26,572 - $80,154
-43,562 Reduced 24.98%
130,795 $180,000
Q4 2021

Feb 14, 2022

BUY
$1.16 - $2.74 $46,516 - $109,874
40,100 Added 29.87%
174,357 $211,000
Q3 2021

Nov 15, 2021

BUY
$2.62 - $5.43 $203,050 - $420,825
77,500 Added 136.55%
134,257 $352,000
Q2 2021

Aug 16, 2021

BUY
$5.06 - $8.15 $68,153 - $109,772
13,469 Added 31.11%
56,757 $301,000
Q1 2021

May 17, 2021

BUY
$6.24 - $9.58 $50,724 - $77,875
8,129 Added 23.12%
43,288 $292,000
Q4 2020

Feb 16, 2021

BUY
$6.28 - $8.79 $220,798 - $309,047
35,159 New
35,159 $238,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.